Viewing nowFamoprazole 10 mg (Famotidine)
Famotidine 10mg
Orally disintegrating Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202202399 · Approved 2022.06.09 · Insurance code 659901790
Treatment of acid-related disorders (e.g., gastric ulcers), treatment of upper gastrointestinal bleeding, and improvement of gastric mucosal lesions
This medication is used for the treatment of peptic ulcers such as gastric ulcers, duodenal ulcers, and anastomotic ulcers. It is also effective for the treatment of acute stress ulcers related to upper gastrointestinal bleeding, hemorrhagic gastritis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It helps improve gastric mucosal lesions such as erosions, bleeding, redness, and edema during acute exacerbations of acute and chronic gastritis. Overall, it is used to treat various ulcerative and inflammatory conditions of the gastrointestinal tract and improve gastric mucosal health.
Gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis), reflux esophagitis, Zollinger-Ellison syndrome: The usual adult dose is 20mg of famotidine orally twice daily (after breakfast and dinner, or at bedtime). Alternatively, 40mg may be administered orally once daily at bedtime. Adjust the dose as appropriate according to age and symptoms. However, in cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and changed to oral administration once the patient is able to take medication by mouth. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: The usual adult dose is 10mg of famotidine orally twice daily (after breakfast and dinner, or at bedtime). Alternatively, 20mg may be administered orally once daily at bedtime. Adjust the dose as appropriate according to age and symptoms. Administration to patients with renal impairment: Famotidine is excreted mainly by the kidneys as unchanged drug. When famotidine is administered to patients with renal impairment, the plasma concentration of unchanged drug increases and urinary excretion decreases as renal function declines. Refer to the following dosing regimen. <For a standard regimen of 20mg twice daily> Ccr ≥ 60: 20mg per dose, twice daily 60 > Ccr > 30: 20mg per dose, once daily; 10mg per dose, twice daily 30 ≥ Ccr: 20mg per dose, once every 2~3 days; 10mg per dose, once daily Patients on dialysis: 20mg per dose, once after dialysis; 10mg per dose, once daily
This medication contains aspartame, an artificial sweetener that is metabolized into phenylalanine in the body. Therefore, patients with phenylketonuria, a hereditary disease, should not take this medication. The daily intake of aspartame should be controlled below the WHO recommended levels, using the minimum amount possible. Patients with hypersensitivity to this medication or similar medications should also avoid taking it. Patients with a history of hypersensitivity, or those with kidney, heart, or liver problems, and the elderly should use this medication with caution. This medication may cause serious allergic reactions, blood abnormalities, skin diseases, liver dysfunction, muscle problems, heart arrhythmias, neurological abnormalities, nephritis, pneumonia, and other serious side effects, so symptoms should be monitored closely. If any adverse effects occur, discontinue use immediately and consult a healthcare professional. Periodic blood tests and kidney and liver function tests should be conducted to monitor for any abnormalities during treatment. This medication dissolves in the mouth but is not absorbed through the oral mucosa, so it must be swallowed with saliva or water. Caution is needed when this medication is taken concurrently with phosphate compounds in dialysis patients, as it may reduce calcium carbonate efficacy. This medication may interact with certain antifungal agents or some anticancer drugs, so caution is necessary when taken together. The elderly may require a reduced dosage or increased dosing interval due to decreased renal function, as the medication may remain longer in the body. Pregnant women should only take this medication if the benefits outweigh the risks, and breastfeeding mothers should discontinue nursing as the medication can pass into breast milk. The safety of this medication for children has not been sufficiently established, so caution is advised. For orally disintegrating tablets, they can be placed on the tongue to dissolve, and can be taken using saliva alone, but should not be taken without water while lying down. Symptoms of stomach cancer may be masked while taking this medication, so it should be taken only after confirming the absence of malignancy.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, the medication should be stored at room temperature, which is not too hot or cold, specifically between 1 to 30 degrees Celsius.
White round orally disintegrating tablet
PTP - 100 tablets/box [10 tablets x 10 PTP], Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFamotidine 10mg
Orally disintegrating Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Famotidine 20mg
Prescription medication
Dong-A ST Co., Ltd.

Famotidine 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Famotidine 20mg
Tablet · Prescription medication
(Stock Company) Ilhwa

Famotidine 20mg
Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Famotidine 20mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Famotidine 20mg
Prescription medication
(Stock Company) Seoul Pharmaceutical

Famotidine 20mg
Tablet · Prescription medication
(Stock Company) Genupharm
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.